x

Posted 16 October, 2023

BIOCEPT INC appointed new CEO

CEO Change detected for ticker Nasdaq:BIOC in a 8-K filed on 16 October, 2023.


  In addition to his resignation from the Company's Board of Directors, Mr. Morales tendered his resignation as the Company's President and Chief Executive Officer effective on October 13, 2023.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of BIOCEPT INC
Health Care/Life Sciences • Healthcare Provision
Biocept, Inc. is an oncology laboratory service company, which engages in the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. The company was founded on May 12, 1997 and is headquartered in San Diego, CA.
Market Cap
$0.00K
View Company Details
BIOCEPT INC by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a "Member" and collectively the "Members") tendered their resignations as members of the Company's Board of Directors which resignations were effective on October 13, 2023, prior to filing the Petition. The resignations of Mr. Morales, Ms. Chandler, Mr. Gerhardt, Ms. Dao-Haddock, Mr. Royston and Ms. Rubinstein are not the result of any disagreements with the Company regarding the Company's operations, policies, or practices. Each of the Members have resigned due to the Company's filing of the Petition which effectively eliminates the powers of the Company's Board of Directors. Following the resignations of the Members, the Company will have no members serving on its Board of Directors.


In addition to his resignation from the Company's Board of Directors, Mr. Morales tendered his resignation as the Company's President and Chief Executive Officer effective on October 13, 2023. The resignation of Mr. Morales was not the result of any disagreement with the Company regarding the Company's operations, policies, or practices. Mr. Morales resigned due to the filing of the Petition which effectively eliminates the powers he previously held on behalf of the Company and the roles of President and Chief Executive Officer.


2